news
New Oncology and Gustave Roussy announce collaboration on genetic testing
14 October 2014 | By New Oncology
New Oncology announced that it has entered into a collaboration agreement with Gustave Roussy Cancer Campus, Paris...
List view / Grid view
Hit-to-Lead
news
Novartis announces clinical collaboration to evaluate Bristol-Myers Squibb’s novel immunotherapy in combination treatments for NSCLC
9 October 2014 | By Novartis
Novartis announced that it has entered into a clinical collaboration with Bristol-Myers Squibb Company to evaluate the safety, tolerability and preliminary efficacy of three molecularly targeted compounds in combination with Bristol-Myers Squibb’s investigational PD-1 immune checkpoint inhibitor, Opdivo® (nivolumab)...
news
Merck Serono to collaborate with The Institute of Cancer Research, London, and Wellcome Trust to co-develop anti-cancer drugs
8 October 2014 | By The Wellcome Trust, The Institute of Cancer Research & Merck Serono
Merck Serono, The Institute of Cancer Research, and the Wellcome Trust, London, have announced a co-development and license agreement building on two independent research programs at both the ICR and Merck Serono to identify inhibitors of tankyrase, an enzyme of the poly (ADP-ribose) polymerase family...
news
OBN celebrates the stars of UK Life Sciences
3 October 2014 | By OBN
OBN revealed last night the winners of its Annual Awards celebrating the best of UK life sciences – the innovators, fundraisers and dealmakers who underline the pre-eminence of the UK sector in the global marketplace...
news
Event preview: Drug Discovery Week Europe
3 October 2014 | By GTCbio
From 7-10 October 2014, GTCbio will proudly present its Drug Discovery Week Europe event in the beautiful city of Dublin, Ireland...
news
Allied-Bristol Life Sciences appoints Satish Jindal to lead the discovery of drug candidates from leading academic institutions
3 October 2014 | By Allied-Bristol Life Sciences
Allied-Bristol Life Sciences today announced that Satish Jindal, Ph.D., formerly Vice President of R&D within Bristol-Myers, has been appointed to lead the company’s efforts to identify and foster development of biopharmaceutical innovations from top U.S. university research institutions...
news
Tumour profiling with Caris Molecular Intelligence offers hope for patients with rare cancers by identifying new personalised treatment options
29 September 2014 | By Caris Life Sciences
Caris Life Sciences announced important new data presented at the European Society for Medical Oncology Annual Conference, highlighting how tumour profiling with Caris Molecular Intelligence can help transform cancer care...
news
Probiodrug announces its intention to launch an Initial Public Offering and listing on Euronext Amsterdam
25 September 2014 | By Probiodrug
Probiodrug AG announces its intention to raise new funds through an Initial Public Offering and listing on Euronext Amsterdam...
news
Horizon Discovery Group plc interim results for the six months ended 30 June 2014
23 September 2014 | By Horizon Discovery
Horizon Discovery Group plc announces its interim results for the six months ended 30 June 2014...
news
Curie-Cancer and Inventiva announce a partnership in epigenetics for the treatment of cancer
16 September 2014 | By Andrew Lloyd & Associates
Curie-Cancer and Inventiva announce the launch of the Epicure project, which has just received financial backing from France’s national research agency, the ANR...
news
Oxford Global’s Drug Discovery USA Congress 2014 new hot topics released & regsitration is closing soon
11 September 2014 | By Oxford Global Conferences
Oxford Global Conferences are proud to present the Drug Discovery USA Congress, taking place on 21 – 22 October at the Hyatt Boston Harbor Hotel, Boston, USA...
news
AstraZeneca announces partnership with Illumina to develop next generation gene sequencing panel for companion diagnostic tests
27 August 2014 | By AstraZeneca
AstraZeneca announced that it has entered into a collaboration with gene sequencing company, Illumina, Inc., to develop its next generation sequencing platform for companion diagnostic tests applicable across AstraZeneca’s oncology portfolio...
news
Yabao Pharmaceuticals and Changzhou Le Sun Pharmaceuticals Ltd. enter an innovative partnership to develop early-stage oncology compound
6 August 2014 | By Yabao Pharmaceutical Co, Inc
Yabao Pharmaceutical Co, Inc. announced a strategic partnership with Changzhou Le Sun Pharmaceuticals Ltd.to co-develop Le Sun's leading PLK/PI3K dual inhibitor LS-008, which currently is under pre-clinical development...
news
Roche to acquire Santaris Pharma to expand discovery and development of RNA-targeting medicines
5 August 2014 | By Roche
Roche announced that it has agreed to acquire Santaris Pharma, a privately held biopharmaceutical company based near Copenhagen, Denmark...
news
Allied Minds and Bristol-Myers Squibb form new enterprise to advance discoveries of biopharmaceutical innovations at leading U.S. academic research
4 August 2014 | By Bristol-Myers Squibb Company
Allied Minds and Bristol-Myers Squibb Company announced the formation of Allied-Bristol Life Sciences LLC, a new jointly owned enterprise created to identify and foster research and pre-clinical development of biopharmaceutical innovations from leading university research institutions across the U.S...
